Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 145
  6. /
  7. D&D Pharma
145
•D&D Pharma•March 5, 2020

FDA 145 - D&D Pharma - March 05, 2020

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This 145 record concerns D&D Pharma, with an inspection on March 5, 2020, covering drugs.

Company
D&D Pharma
Inspection Date
March 5, 2020
Product Type
Drugs
Person
  • Nicholas F. Lyons (Director of Compliance)
Open in Dashboard

ID · b04f0177-0dad-4186-8295-0ad0bdc2cef9

Violation Codes6
21 CFR 211.22(a)FD&C Act 501(a)(2)(B)21 CFR 211.167(a)21 CFR 211.42(c)21 CFR 211.165(f)21 CFR 211.28(b)

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.